Eltrombopag
Red
Brand:
Revolade®
Nice TA:
293
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Blood and Nutrition
Background
Eltrombopag is recommended as an option for treating chronic immune (idiopathic) thrombocytopenic purpura in adults, only if:
- their condition is refractory to standard active treatments and rescue therapies or
- they have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies